Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Human Papillomavirus Vaccines: Successes and Future Challenges
Samara Perez, Gregory D. Zimet, Ovidiu Tatar, et al.
Drugs (2018) Vol. 78, Iss. 14, pp. 1385-1396
Closed Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

HPV-Related Papillary Lesions of the Oral Mucosa: A Review
Sasha J. Betz
Head and Neck Pathology (2019) Vol. 13, Iss. 1, pp. 80-90
Open Access | Times Cited: 96
Policy opportunities to increase HPV vaccination in rural communities
Robin C. Vanderpool, Lindsay R. Stradtman, Heather M. Brandt
Human Vaccines & Immunotherapeutics (2019) Vol. 15, Iss. 7-8, pp. 1527-1532
Open Access | Times Cited: 56
A systematic literature review of human papillomavirus vaccination strategies in delivery systems within national and regional immunization programs
Marisa Felsher, Meheret Shumet, Cristinela Velicu, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 6
National introduction of human papillomavirus (HPV) vaccine in Tanzania: Programmatic decision-making and implementation
Alex Mphuru, Anyie J. Li, Furaha Kyesi, et al.
Vaccine (2021) Vol. 40, pp. A2-A9
Open Access | Times Cited: 34
Knowledge, attitudes and acceptance toward Human papillomavirus (HPV) vaccination: Perspectives of Muslim women and men
Salma Al Alawi, Omar Al Zaabi, Margaret Heffernan, et al.
Vaccine (2023) Vol. 41, Iss. 13, pp. 2224-2233
Closed Access | Times Cited: 14
Chinese mothers’ intention to vaccinate daughters against human papillomavirus (HPV), and their vaccine preferences: a study in Fujian Province
Yulan Lin, Zhitai Su, Fulian Chen, et al.
Human Vaccines & Immunotherapeutics (2020) Vol. 17, Iss. 1, pp. 304-315
Open Access | Times Cited: 33
Immunomodulatory potential of chitosan-based materials for cancer therapy: a systematic review of in vitro, in vivo and clinical studies
Beatriz V. Lima, Maria José Oliveira, Mário A. Barbosa, et al.
Biomaterials Science (2021) Vol. 9, Iss. 9, pp. 3209-3227
Closed Access | Times Cited: 31
Lipid Nanoparticles for mRNA Delivery to Enhance Cancer Immunotherapy
Hongli Wang, Zhi‐Gang Wang, Shu‐Lin Liu
Molecules (2022) Vol. 27, Iss. 17, pp. 5607-5607
Open Access | Times Cited: 22
Barriers in the School-Based Pan-Gender HPV Vaccination Program in Sweden: Healthcare Providers’ Perspective
Ida Enskär, Karin Enskär, Tryggve Nevéus, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 310-310
Open Access | Times Cited: 9
Adolescent Consent for Human Papillomavirus Vaccine: Ethical, Legal, and Practical Considerations
Gregory D. Zimet, Ross D. Silverman, Robert A. Bednarczyk, et al.
The Journal of Pediatrics (2021) Vol. 231, pp. 24-30
Open Access | Times Cited: 22
Increasing HPV Vaccination Coverage Through Provider-Based Interventions
Landon Krantz, Nicholas J. Ollberding, Andrew F. Beck, et al.
Clinical Pediatrics (2017) Vol. 57, Iss. 3, pp. 319-326
Closed Access | Times Cited: 26
Progress in Vaccination of Prophylactic Human Papillomavirus Vaccine
Xu Zhou, Lihua Sun, Xiaoxiao Yao, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 23
Exosomes from HPV-16 E7-pulsed dendritic cells prevent the migration, M1 polarization, and inflammation of macrophages in cervical cancer by regulating catalase 2 (CAT2)
Guangping Zhang, Yanan Liao, Xiaoping Pan, et al.
Annals of Translational Medicine (2022) Vol. 10, Iss. 4, pp. 217-217
Open Access | Times Cited: 13
Tanzania’s human papillomavirus (HPV) vaccination program: Community awareness, feasibility, and acceptability of a national HPV vaccination program, 2019
Anyie J. Li, Fatuma Manzi, Furaha Kyesi, et al.
Vaccine (2021) Vol. 40, pp. A38-A48
Open Access | Times Cited: 16
Uptake of the HPV vaccine among people with and without HIV, cisgender and transgender women and men who have sex with men and with women at two sexual health clinics in Mexico City
Betania Allen‐Leigh, Leonor Rivera-Rivera, Elsa Yunes-Díaz, et al.
Human Vaccines & Immunotherapeutics (2019) Vol. 16, Iss. 4, pp. 981-990
Open Access | Times Cited: 18
MicroRNA-625-5p Sponges lncRNA MALAT1 to Inhibit Cervical Carcinoma Cell Growth by Suppressing NF-κB Signaling
Yujiao Li, Yumei Ding, Ning Ding, et al.
Cell Biochemistry and Biophysics (2020) Vol. 78, Iss. 2, pp. 217-225
Closed Access | Times Cited: 16
Surveillance of adverse events following immunization related to human papillomavirus vaccines: 12 years of vaccinovigilance in Southern Italy
Cristina Scavone, Cristina Di Mauro, Simona Brusco, et al.
Expert Opinion on Drug Safety (2019) Vol. 18, Iss. 5, pp. 427-433
Closed Access | Times Cited: 15
Human Papillomavirus Genotype Detection in Oral Gargle Samples Among Men With Newly Diagnosed Oropharyngeal Squamous Cell Carcinoma
Laura Martin‐Gomez, Anna R. Giuliano, William J. Fulp, et al.
JAMA Otolaryngology–Head & Neck Surgery (2019) Vol. 145, Iss. 5, pp. 460-460
Open Access | Times Cited: 14
Exploring attitudes of adolescents and caregivers towards community-based delivery of the HPV vaccine: a qualitative study
Shoba Ramanadhan, Constance P. Fontanet, M Teixeira, et al.
BMC Public Health (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 13
Health Care Professionals’ Interest in Vaccination Training in Switzerland: A Quantitative Survey
Pia Lucas Ramanathan, Nadja Baldesberger, Léna G. Dietrich, et al.
International Journal of Public Health (2022) Vol. 67
Open Access | Times Cited: 8
HPV vaccine acceptance is high among adults in Mexico, particularly in people living with HIV
Alejandra Portillo-Romero, Leith León‐Maldonado, Betania Allen‐Leigh, et al.
Salud Pública de México (2018) Vol. 60, Iss. 6, nov-dic, pp. 658-658
Open Access | Times Cited: 10
There’s Much Yet to be Done: Diverse Perspectives on HPV Vaccination
Gregory D. Zimet, Nosayaba Osazuwa‐Peters
Human Vaccines & Immunotherapeutics (2019) Vol. 15, Iss. 7-8, pp. 1459-1464
Open Access | Times Cited: 10
Stated preferences for human papillomavirus vaccination for adolescents in selected communities in Ibadan, Southwest Nigeria: A discrete choice experiment
Folusho Mubowale Balogun, Olayemi O. Omotade, Mikael Svensson
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 6
Open Access | Times Cited: 5
Medical students’ knowledge of the human papillomavirus (HPV), cervical cancer, and HPV vaccination
Miriam da Silva Wanderley, Dejano T. Sobral, Ceres Nunes Resende, et al.
Revista Brasileira de Educação Médica (2021) Vol. 45, Iss. 3
Open Access | Times Cited: 7
An assessment of risk compensation and spillover behavioural adaptions associated with the use of vaccines in animal disease management
Gareth Enticott, Damian Maye, Rhiannon Naylor, et al.
Vaccine (2019) Vol. 38, Iss. 5, pp. 1065-1075
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top